Pub Date : 2026-03-01Epub Date: 2025-11-02DOI: 10.1111/coa.70055
İrem Damla Güver Çalapkulu, Zehra Betul Paksoy, İbrahim Sevim, Süleyman Boynueğri
Objective: This study aimed to evaluate the long-term effects of upper airway surgery on olfactory (orthonasal and retronasal) and gustatory functions in patients with obstructive sleep apnoea syndrome (OSAS). Sensory outcomes were compared between surgically treated patients and newly diagnosed OSAS patients who had not received surgery or Positive Airway Pressure (PAP) therapy. In addition, the influence of surgical technique on investigated parameters was analyzed.
Materials and methods: This prospective study included 49 patients aged 18-75 years with OSAS, divided into a surgical group (n = 25) and a control group (n = 24). The surgical group had undergone at least one of the following procedures more than 1 year prior: anterior palatoplasty, expansion sphincter pharyngoplasty, lateral pharyngoplasty, tongue base coblation, or epiglottopexy. Orthonasal olfaction was assessed using the Connecticut Chemosensory Clinical Research Centre (CCCRC) test; retronasal olfaction using a validated 20-item powder-based test; and gustatory function with taste strips for sweet, salty, sour, and bitter.
Results: There were no significant differences between the surgery and control groups in terms of age, apnoea-hypopnoea index (AHI), retronasal olfactory scores, orthonasal threshold, identification, mean CCCRC scores, or gustatory scores (p = 0.218, 0.912, 0.464, 0.111, 0.952, 0.423, and 0.738, respectively). In contrast, a strong and statistically significant correlation was found between retronasal and mean CCCRC scores (Spearman's r = 0.653, p < 0.001).
Conclusion: Upper airway surgery does not appear to adversely affect long-term olfactory or gustatory function in OSAS patients. The high correlation between orthonasal and retronasal scores supports their combined use in sensory evaluation. These findings suggest that surgery is safe with regard to smell and taste perception.
目的:本研究旨在评价上呼吸道手术对阻塞性睡眠呼吸暂停综合征(OSAS)患者嗅觉(正鼻和后鼻)和味觉功能的长期影响。比较手术治疗患者和未接受手术或气道正压(PAP)治疗的新诊断OSAS患者的感觉结果。此外,还分析了手术技术对研究参数的影响。材料与方法:本前瞻性研究纳入49例18-75岁的OSAS患者,分为手术组(n = 25)和对照组(n = 24)。手术组在1年前至少接受过以下手术之一:前腭成形术、扩张括约肌咽成形术、侧咽成形术、舌底消融或会音固定术。使用康涅狄格化学感觉临床研究中心(CCCRC)测试评估正交鼻嗅觉;使用经过验证的20项粉末测试进行后鼻嗅觉;还有味觉功能,有甜、咸、酸、苦的味觉条。结果:手术组与对照组在年龄、呼吸暂停低通气指数(AHI)、后鼻嗅觉评分、正鼻阈值、鉴别、CCCRC平均评分、味觉评分方面差异均无统计学意义(p分别为0.218、0.912、0.464、0.111、0.952、0.423、0.738)。相比之下,后鼻和平均CCCRC评分之间存在显著的相关性(Spearman’s r = 0.653, p)。结论:上呼吸道手术对OSAS患者的长期嗅觉或味觉功能没有不良影响。正鼻和后鼻评分之间的高度相关性支持它们在感觉评估中的联合使用。这些发现表明手术对于嗅觉和味觉感知是安全的。
{"title":"Long-Term Outcomes of Orthonasal, Retronasal Olfactory and Gustatory Functions in Patients Undergoing Surgery for Obstructive Sleep Apnea Syndrome.","authors":"İrem Damla Güver Çalapkulu, Zehra Betul Paksoy, İbrahim Sevim, Süleyman Boynueğri","doi":"10.1111/coa.70055","DOIUrl":"10.1111/coa.70055","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the long-term effects of upper airway surgery on olfactory (orthonasal and retronasal) and gustatory functions in patients with obstructive sleep apnoea syndrome (OSAS). Sensory outcomes were compared between surgically treated patients and newly diagnosed OSAS patients who had not received surgery or Positive Airway Pressure (PAP) therapy. In addition, the influence of surgical technique on investigated parameters was analyzed.</p><p><strong>Materials and methods: </strong>This prospective study included 49 patients aged 18-75 years with OSAS, divided into a surgical group (n = 25) and a control group (n = 24). The surgical group had undergone at least one of the following procedures more than 1 year prior: anterior palatoplasty, expansion sphincter pharyngoplasty, lateral pharyngoplasty, tongue base coblation, or epiglottopexy. Orthonasal olfaction was assessed using the Connecticut Chemosensory Clinical Research Centre (CCCRC) test; retronasal olfaction using a validated 20-item powder-based test; and gustatory function with taste strips for sweet, salty, sour, and bitter.</p><p><strong>Results: </strong>There were no significant differences between the surgery and control groups in terms of age, apnoea-hypopnoea index (AHI), retronasal olfactory scores, orthonasal threshold, identification, mean CCCRC scores, or gustatory scores (p = 0.218, 0.912, 0.464, 0.111, 0.952, 0.423, and 0.738, respectively). In contrast, a strong and statistically significant correlation was found between retronasal and mean CCCRC scores (Spearman's r = 0.653, p < 0.001).</p><p><strong>Conclusion: </strong>Upper airway surgery does not appear to adversely affect long-term olfactory or gustatory function in OSAS patients. The high correlation between orthonasal and retronasal scores supports their combined use in sensory evaluation. These findings suggest that surgery is safe with regard to smell and taste perception.</p>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":" ","pages":"269-274"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145430431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-11-26DOI: 10.1111/coa.70063
Seraphina Key, Matthew Kwok, Timothy McLean
Objective: The role of elective neck dissection (END) in clinically node negative (cN0) locally advanced cutaneous squamous cell carcinoma (cSCC) of the head and neck on survival outcomes is not well elucidated. To date, there is no systematic review performed on the role of END in cN0 disease for advanced cSCC. This study aims to determine if END affects survival outcomes compared to observation.
Design: Systematic review from inception to 22 June 2025 of three peer-reviewed databases (MEDLINE, Embase, Scopus), two clinical trial registries (Clinicaltrials.gov, ANZCTR) and grey literature (Scopus), for MeSH terms pertaining to 'elective neck dissection', 'cutaneous squamous cell carcinoma' and 'head and neck'. This review was registered prospectively on PROSPERO (CRD42024537410).
Participants: END in patients with cN0 locally advanced head and neck cSCC.
Main outcome measures: Overall survival (OS), disease-specific survival (DSS) and disease-free survival (DFS).
Results: Of 983 unique studies, 119 studies underwent full-text screening. Six studies underwent systematic review and meta-analysis. Of 522 included patients, 197 (37.7%) underwent END and 325 (62.3%) underwent observation. Six studies reported on OS, four studies on DSS and three on DFS. Meta-analysis for OS at 5 years did not provide a conclusion for or against END (log risk-ratio 0.09, 95% CI -0.57 to 0.76). Meta-analysis could not be performed for DSS. The meta-analysed occult cervical nodal rate was 17.34% (95% CI 10.57 to 25.14). Studies were of low to moderate risk of bias.
Conclusion: In locally advanced cSCC, END cannot be conclusively stated to improve OS or DSS.
目的:择期颈部清扫术(END)在临床上淋巴结阴性(cN0)局部晚期头颈部皮肤鳞状细胞癌(cSCC)患者的生存预后中的作用尚不清楚。迄今为止,尚无关于END在晚期cSCC的cN0疾病中的作用的系统综述。本研究旨在确定与观察相比,END是否会影响生存结果。设计:对三个同行评审数据库(MEDLINE、Embase、Scopus)、两个临床试验注册库(Clinicaltrials.gov、ANZCTR)和灰色文献(Scopus)从成立到2025年6月22日进行系统评价,包括与“选择性颈部解剖”、“皮肤鳞状细胞癌”和“头颈部”相关的MeSH术语。本综述在PROSPERO (CRD42024537410)前瞻性注册。参与者:cN0局部晚期头颈部cSCC患者的END。主要结局指标:总生存期(OS)、疾病特异性生存期(DSS)和无病生存期(DFS)。结果:在983项独特研究中,119项研究进行了全文筛选。对6项研究进行了系统回顾和荟萃分析。522例纳入的患者中,197例(37.7%)接受END治疗,325例(62.3%)接受观察。6项OS研究报告,4项DSS研究报告,3项DFS研究报告。5年OS的荟萃分析没有提供支持或反对END的结论(对数风险比0.09,95% CI -0.57至0.76)。不能对DSS进行meta分析。荟萃分析的隐匿性宫颈结率为17.34% (95% CI 10.57 ~ 25.14)。研究偏倚风险为低至中等。结论:在局部晚期cSCC中,END不能决定性地改善OS或DSS。
{"title":"Elective Neck Dissection in Advanced Cutaneous Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.","authors":"Seraphina Key, Matthew Kwok, Timothy McLean","doi":"10.1111/coa.70063","DOIUrl":"10.1111/coa.70063","url":null,"abstract":"<p><strong>Objective: </strong>The role of elective neck dissection (END) in clinically node negative (cN0) locally advanced cutaneous squamous cell carcinoma (cSCC) of the head and neck on survival outcomes is not well elucidated. To date, there is no systematic review performed on the role of END in cN0 disease for advanced cSCC. This study aims to determine if END affects survival outcomes compared to observation.</p><p><strong>Design: </strong>Systematic review from inception to 22 June 2025 of three peer-reviewed databases (MEDLINE, Embase, Scopus), two clinical trial registries (Clinicaltrials.gov, ANZCTR) and grey literature (Scopus), for MeSH terms pertaining to 'elective neck dissection', 'cutaneous squamous cell carcinoma' and 'head and neck'. This review was registered prospectively on PROSPERO (CRD42024537410).</p><p><strong>Participants: </strong>END in patients with cN0 locally advanced head and neck cSCC.</p><p><strong>Main outcome measures: </strong>Overall survival (OS), disease-specific survival (DSS) and disease-free survival (DFS).</p><p><strong>Results: </strong>Of 983 unique studies, 119 studies underwent full-text screening. Six studies underwent systematic review and meta-analysis. Of 522 included patients, 197 (37.7%) underwent END and 325 (62.3%) underwent observation. Six studies reported on OS, four studies on DSS and three on DFS. Meta-analysis for OS at 5 years did not provide a conclusion for or against END (log risk-ratio 0.09, 95% CI -0.57 to 0.76). Meta-analysis could not be performed for DSS. The meta-analysed occult cervical nodal rate was 17.34% (95% CI 10.57 to 25.14). Studies were of low to moderate risk of bias.</p><p><strong>Conclusion: </strong>In locally advanced cSCC, END cannot be conclusively stated to improve OS or DSS.</p>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":" ","pages":"203-212"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145630615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-11-12DOI: 10.1111/coa.70059
Elsa-Leea Kotola, Johanna Wikstén, Eeva Castrén
{"title":"Polidocanol Sclerotherapy in Hereditary Hemorrhagic Telangiectasia Patients Does Not Seem to Decrease Epistaxis-Related Outpatient and Emergency Visits-A Retrospective View.","authors":"Elsa-Leea Kotola, Johanna Wikstén, Eeva Castrén","doi":"10.1111/coa.70059","DOIUrl":"10.1111/coa.70059","url":null,"abstract":"","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":" ","pages":"356-359"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12868990/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145502503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-12-01DOI: 10.1111/coa.70064
Alexander J M Curran, Sarah Ellis, May M C Yaneza
Introduction: Sleep-disordered breathing (SDB) affects up to 5% of children and is associated with multiple systemic complications. Recent concerns over rare but fatal choking incidents in children with untreated obstructive SDB (oSDB) have developed interest in whether swallowing dysfunction is a contributing factor. This systematic review investigates whether there is evidence linking paediatric oSDB with swallowing disorders, excluding children with known neurological or craniofacial comorbidities.
Methods: A systematic literature search was conducted across Embase, PubMed, CINAHL, and Cochrane databases (11th November 2024), using PRISMA 2020 guidelines. Studies were included if they involved children with oSDB and reported swallowing assessments. Exclusion criteria included non-English publications, patients with syndromic or craniofacial conditions, and studies lacking primary data. The risk of bias was assessed using ROBINS-I.
Results: Nine studies met the inclusion criteria. Reported prevalence of swallowing dysfunction ranged from 4% to 70%, with evidence of both oral-phase (e.g., atypical deglutition, reduced mastication) and pharyngeal-phase (e.g., choking, prolonged feeding) abnormalities. Outcome measures varied widely, with only two studies employing a validated swallowing tool. Three studies indicated that treatment of oSDB (adenotonsillectomy or myofunctional therapy) may improve swallowing symptoms. The quality of evidence was low, with most studies showing moderate to serious risk of bias.
Conclusion: There is limited, low-quality evidence suggestive that children with oSDB are at increased risk of swallowing dysfunction. However, heterogeneity in definitions, assessment tools, and study design limits the ability to draw firm conclusions. Episodes of severe swallowing-related complications such as fatal aspiration or choking are rare but clinicians should consider swallowing issues in these patients. Further research with standardised, objective assessments is required to understand better the relationship between SDB and swallowing in children. Early evidence indicates that treated oSDB may improve swallow-related symptoms, but more studies are required before official practice recommendations. Overall, this systematic review highlights a possible link between oSDB and swallowing dysfunction emphasising the need for further objective research to guide clinical care for these patients.
{"title":"A Systematic Review to Assess Swallowing Disorders in Paediatric Patients With Sleep-Disordered Breathing.","authors":"Alexander J M Curran, Sarah Ellis, May M C Yaneza","doi":"10.1111/coa.70064","DOIUrl":"10.1111/coa.70064","url":null,"abstract":"<p><strong>Introduction: </strong>Sleep-disordered breathing (SDB) affects up to 5% of children and is associated with multiple systemic complications. Recent concerns over rare but fatal choking incidents in children with untreated obstructive SDB (oSDB) have developed interest in whether swallowing dysfunction is a contributing factor. This systematic review investigates whether there is evidence linking paediatric oSDB with swallowing disorders, excluding children with known neurological or craniofacial comorbidities.</p><p><strong>Methods: </strong>A systematic literature search was conducted across Embase, PubMed, CINAHL, and Cochrane databases (11th November 2024), using PRISMA 2020 guidelines. Studies were included if they involved children with oSDB and reported swallowing assessments. Exclusion criteria included non-English publications, patients with syndromic or craniofacial conditions, and studies lacking primary data. The risk of bias was assessed using ROBINS-I.</p><p><strong>Results: </strong>Nine studies met the inclusion criteria. Reported prevalence of swallowing dysfunction ranged from 4% to 70%, with evidence of both oral-phase (e.g., atypical deglutition, reduced mastication) and pharyngeal-phase (e.g., choking, prolonged feeding) abnormalities. Outcome measures varied widely, with only two studies employing a validated swallowing tool. Three studies indicated that treatment of oSDB (adenotonsillectomy or myofunctional therapy) may improve swallowing symptoms. The quality of evidence was low, with most studies showing moderate to serious risk of bias.</p><p><strong>Conclusion: </strong>There is limited, low-quality evidence suggestive that children with oSDB are at increased risk of swallowing dysfunction. However, heterogeneity in definitions, assessment tools, and study design limits the ability to draw firm conclusions. Episodes of severe swallowing-related complications such as fatal aspiration or choking are rare but clinicians should consider swallowing issues in these patients. Further research with standardised, objective assessments is required to understand better the relationship between SDB and swallowing in children. Early evidence indicates that treated oSDB may improve swallow-related symptoms, but more studies are required before official practice recommendations. Overall, this systematic review highlights a possible link between oSDB and swallowing dysfunction emphasising the need for further objective research to guide clinical care for these patients.</p>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":" ","pages":"213-221"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-12-12DOI: 10.1111/coa.70075
Mehmet Korkmaz, Fakih Cihat Eravcı, Malik Afifoğlu, Nursultan Abakır, Mehmet Akif Eryılmaz, Hamdi Arbağ
Objective: This study aimed to evaluate the effect of postoperative oral antihistamine (clemastine) use on the incidence of salivary fistula and sialocele in patients undergoing superficial parotidectomy.
Materials and methods: A retrospective analysis was conducted on 202 patients who underwent superficial parotidectomy for benign parotid tumours at the Department of Otolaryngology-Head and Neck Surgery, Necmettin Erbakan University, between 2020 and 2024. All patients were prescribed clemastine-containing antihistamines postoperatively; however, they were divided into two groups based on their access to and use of the medication. The development of salivary fistula and sialocele was assessed clinically. Data were analysed using Fisher's exact test, and p < 0.05 was considered statistically significant.
Results: Salivary fistula was observed in 5 of 164 patients (3.0%) in the antihistamine group and in 5 of 38 patients (13.2%) in the non-user group. This difference was statistically significant (p = 0.022). The incidence of sialocele was three (1.8%) in the antihistamine group and two (5.3%) in the non-user group, with no significant difference between the groups (p = 0.237). The most common side effects in patients receiving antihistamines were drowsiness (12.1%), accommodation disorders (9.1%) and other mild anticholinergic symptoms.
Conclusion: Oral antihistamine use following superficial parotidectomy may significantly reduce the incidence of salivary fistula. Most adverse effects were mild and tolerable. These findings suggest a potential benefit of antihistamines in the prevention of postoperative complications.
{"title":"Does Oral Antihistamine Use Reduce the Risk of Salivary Fistula Following Superficial Parotidectomy? A Retrospective Study.","authors":"Mehmet Korkmaz, Fakih Cihat Eravcı, Malik Afifoğlu, Nursultan Abakır, Mehmet Akif Eryılmaz, Hamdi Arbağ","doi":"10.1111/coa.70075","DOIUrl":"10.1111/coa.70075","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the effect of postoperative oral antihistamine (clemastine) use on the incidence of salivary fistula and sialocele in patients undergoing superficial parotidectomy.</p><p><strong>Materials and methods: </strong>A retrospective analysis was conducted on 202 patients who underwent superficial parotidectomy for benign parotid tumours at the Department of Otolaryngology-Head and Neck Surgery, Necmettin Erbakan University, between 2020 and 2024. All patients were prescribed clemastine-containing antihistamines postoperatively; however, they were divided into two groups based on their access to and use of the medication. The development of salivary fistula and sialocele was assessed clinically. Data were analysed using Fisher's exact test, and p < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>Salivary fistula was observed in 5 of 164 patients (3.0%) in the antihistamine group and in 5 of 38 patients (13.2%) in the non-user group. This difference was statistically significant (p = 0.022). The incidence of sialocele was three (1.8%) in the antihistamine group and two (5.3%) in the non-user group, with no significant difference between the groups (p = 0.237). The most common side effects in patients receiving antihistamines were drowsiness (12.1%), accommodation disorders (9.1%) and other mild anticholinergic symptoms.</p><p><strong>Conclusion: </strong>Oral antihistamine use following superficial parotidectomy may significantly reduce the incidence of salivary fistula. Most adverse effects were mild and tolerable. These findings suggest a potential benefit of antihistamines in the prevention of postoperative complications.</p>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":" ","pages":"335-340"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: This study aimed to evaluate the efficacy of platelet-rich plasma (PRP), a biologic agent that facilitates tissue regeneration and wound healing, in improving postoperative outcomes of frontal sinus ostium (FSO) and need for postoperative intervention.
Materials and methods: A prospective, randomised controlled trial included chronic rhinosinusitis (CRS) patients undergoing bilateral endoscopic frontal sinus surgery. PRP-soaked absorbable hemostat was applied to the frontal sinus ostium on the randomised side, while a plain absorbable hemostat was used on the control side. Endoscopic evaluations were conducted intraoperatively (baseline), and at 30 and 90 days postoperatively to assess the FSO area, FSO patency, inflammatory visual analog scale (VAS) score, presence of polypoid edema, adhesion/scarring grade, and the need for postoperative interventions.
Results: Thirty participants were enrolled and PRP was applied to 30 frontal sinus ostia on randomised side. On 30-day post-ESS PRP significantly improved inflammatory VAS score (p = 0.041), reduced polypoid edema (odds ratio (OR) 0.49; 95% CI: 0.24, 0.98) and adhesion scarring (OR 0.33; 95% CI: 0.15, 0.74), and improved the need of postoperative intervention compared to the control (risk ratio (RR) 0.25; 95% CI: 0.11, 0.58). On 90-day post-ESS, PRP significantly reduced polypoid edema (OR 0.35; 95% CI: 0.17, 0.67), and adhesion scarring (OR 0.20; 95% CI 0.07, 0.52) compared to the control. The FSO area changes and patency grade were not significantly different between groups.
Conclusion: The PRP application following frontal sinusotomy improved the inflammatory VAS score, polypoid edema and adhesion scarring grades, and reduces the need for oral steroid intervention.
{"title":"Efficacy of Platelet-Rich Plasma (PRP) on Post-Surgical Outcomes Following Endoscopic Frontal Sinusotomy: A Randomised Controlled Trial.","authors":"Pattranit Pakpattaraphaiboon, Kawinyarat Jitaroon, Suphakrit Limpornpugdee","doi":"10.1111/coa.70062","DOIUrl":"10.1111/coa.70062","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the efficacy of platelet-rich plasma (PRP), a biologic agent that facilitates tissue regeneration and wound healing, in improving postoperative outcomes of frontal sinus ostium (FSO) and need for postoperative intervention.</p><p><strong>Materials and methods: </strong>A prospective, randomised controlled trial included chronic rhinosinusitis (CRS) patients undergoing bilateral endoscopic frontal sinus surgery. PRP-soaked absorbable hemostat was applied to the frontal sinus ostium on the randomised side, while a plain absorbable hemostat was used on the control side. Endoscopic evaluations were conducted intraoperatively (baseline), and at 30 and 90 days postoperatively to assess the FSO area, FSO patency, inflammatory visual analog scale (VAS) score, presence of polypoid edema, adhesion/scarring grade, and the need for postoperative interventions.</p><p><strong>Results: </strong>Thirty participants were enrolled and PRP was applied to 30 frontal sinus ostia on randomised side. On 30-day post-ESS PRP significantly improved inflammatory VAS score (p = 0.041), reduced polypoid edema (odds ratio (OR) 0.49; 95% CI: 0.24, 0.98) and adhesion scarring (OR 0.33; 95% CI: 0.15, 0.74), and improved the need of postoperative intervention compared to the control (risk ratio (RR) 0.25; 95% CI: 0.11, 0.58). On 90-day post-ESS, PRP significantly reduced polypoid edema (OR 0.35; 95% CI: 0.17, 0.67), and adhesion scarring (OR 0.20; 95% CI 0.07, 0.52) compared to the control. The FSO area changes and patency grade were not significantly different between groups.</p><p><strong>Conclusion: </strong>The PRP application following frontal sinusotomy improved the inflammatory VAS score, polypoid edema and adhesion scarring grades, and reduces the need for oral steroid intervention.</p>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":" ","pages":"296-306"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145596164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elizabeth Mairenn Garden, Gabija Klyvyte, Andreas Espehana, Louis Luke, Amaya Sainz de la Maza Melon, Morgan Hardy, Tharsika Myuran, Allan Clark, Carl Philpott
Background: Head trauma is a major cause of chemosensory deficit, with olfactory loss occurring in approximately 22% of cases. Following head injury, olfactory and gustatory loss are often unassessed; patients are often unaware of the problem, thus presenting late to specialist clinics.
Primary aim: To determine the role of screening olfactory and gustatory testing in patients following head trauma.
Methods: This prospective cohort study, conducted at three secondary hospitals, included patients with head injury aged ≥ 18 years, with capacity to consent within 30 days of injury. Patients with previous head injury requiring admission or with pre-existing olfactory/gustatory loss were excluded. Participants underwent screening chemosensory assessment using Burghart Sniffin' Sticks and Taste Strips. If significant loss was identified, patients were referred to Smell & Taste clinic to be seen within 3 months of injury for extended testing.
Results: A total of 121 participants took part in the study (65 male, 56 female); 71% experienced olfactory dysfunction and 62% gustatory dysfunction post head injury. There was no statistically significant association between gender and olfactory/gustatory dysfunction (p > 0.05). Older participants experienced a higher prevalence of olfactory and gustatory dysfunction. Seven participants progressed to a follow-up consultation in the Smell & Taste Clinic, all of whom had persistent olfactory dysfunction.
Conclusion: Our study highlights that a significant proportion of mild head injuries result in olfactory/gustatory dysfunction, thus reinforcing the use of psychophysical testing in this patient cohort. Improvements should be made to ensure they receive suitable follow-up in a Smell & Taste clinic.
{"title":"A Prospective Cohort Study Investigating the Role of a Screening Smell and Taste Test in Patients Following Head Injury.","authors":"Elizabeth Mairenn Garden, Gabija Klyvyte, Andreas Espehana, Louis Luke, Amaya Sainz de la Maza Melon, Morgan Hardy, Tharsika Myuran, Allan Clark, Carl Philpott","doi":"10.1111/coa.70090","DOIUrl":"https://doi.org/10.1111/coa.70090","url":null,"abstract":"<p><strong>Background: </strong>Head trauma is a major cause of chemosensory deficit, with olfactory loss occurring in approximately 22% of cases. Following head injury, olfactory and gustatory loss are often unassessed; patients are often unaware of the problem, thus presenting late to specialist clinics.</p><p><strong>Primary aim: </strong>To determine the role of screening olfactory and gustatory testing in patients following head trauma.</p><p><strong>Methods: </strong>This prospective cohort study, conducted at three secondary hospitals, included patients with head injury aged ≥ 18 years, with capacity to consent within 30 days of injury. Patients with previous head injury requiring admission or with pre-existing olfactory/gustatory loss were excluded. Participants underwent screening chemosensory assessment using Burghart Sniffin' Sticks and Taste Strips. If significant loss was identified, patients were referred to Smell & Taste clinic to be seen within 3 months of injury for extended testing.</p><p><strong>Results: </strong>A total of 121 participants took part in the study (65 male, 56 female); 71% experienced olfactory dysfunction and 62% gustatory dysfunction post head injury. There was no statistically significant association between gender and olfactory/gustatory dysfunction (p > 0.05). Older participants experienced a higher prevalence of olfactory and gustatory dysfunction. Seven participants progressed to a follow-up consultation in the Smell & Taste Clinic, all of whom had persistent olfactory dysfunction.</p><p><strong>Conclusion: </strong>Our study highlights that a significant proportion of mild head injuries result in olfactory/gustatory dysfunction, thus reinforcing the use of psychophysical testing in this patient cohort. Improvements should be made to ensure they receive suitable follow-up in a Smell & Taste clinic.</p>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
William Ansley, Gabija Klyvyte, Mehmet Ergisi, Natalia Glibbery, Lois Camp, Prajakta Choudari, Mohammed Jawad, Tharsika Myuran, Nikki Garner, Jane Vennik, Lorenzo Stafford, Felix Naughton, Duncan Boak, Carl Philpott
Objectives: Smell and taste disorders (SATDs) are frequently overlooked despite growing prevalence. They profoundly impact quality of life. Effective therapies for SATDs remain scarce. This survey aimed to assess patient views surrounding the support available at the time of onset of SATDs, and what further support is needed.
Design and setting: This was a cross-sectional study consisting of an online survey circulated via the UK charity SmellTaste (known as Fifth Sense until a rebrand in May 2025), exploring features and impacts of SATDs, and opinions surrounding support available, and any further support felt to be necessary by those formally diagnosed or self-identifying with SATDs.
Main outcomes: Survey questions were grouped largely into the domains of demographics, features of olfactory issues, impact of disorder, and support network.
Results: A total of 410 participants completed the questionnaire, with the majority being women. When asked how olfactory dysfunction made participants feel, common responses included: 'sad', 'devastated', 'angry', 'anxious', 'depressed', 'isolated' and 'grief'. Family was reported as the greatest source of support when diagnosed with SATDs (partner/spouse, 36.4%; other family member, 15.1%) followed closely by SmellTaste (34%). Only 2.5% reported General Practitioners as their greatest source of support, with many participants reporting that primary care providers could not provide adequate help, leaving them to seek advice elsewhere (support groups, family, friends and self-investigation). Further support, covering medical, psychological and social interventions, was considered important.
Conclusion: Given the complexity of issues experienced and the lack of formal support available for people with SATDs, there is a clear need for an intervention addressing unmet support needs.
{"title":"A Cross-Sectional Study Exploring Patient Experiences, Unmet Needs and Desired Support in Those With Olfactory Dysfunction.","authors":"William Ansley, Gabija Klyvyte, Mehmet Ergisi, Natalia Glibbery, Lois Camp, Prajakta Choudari, Mohammed Jawad, Tharsika Myuran, Nikki Garner, Jane Vennik, Lorenzo Stafford, Felix Naughton, Duncan Boak, Carl Philpott","doi":"10.1111/coa.70091","DOIUrl":"https://doi.org/10.1111/coa.70091","url":null,"abstract":"<p><strong>Objectives: </strong>Smell and taste disorders (SATDs) are frequently overlooked despite growing prevalence. They profoundly impact quality of life. Effective therapies for SATDs remain scarce. This survey aimed to assess patient views surrounding the support available at the time of onset of SATDs, and what further support is needed.</p><p><strong>Design and setting: </strong>This was a cross-sectional study consisting of an online survey circulated via the UK charity SmellTaste (known as Fifth Sense until a rebrand in May 2025), exploring features and impacts of SATDs, and opinions surrounding support available, and any further support felt to be necessary by those formally diagnosed or self-identifying with SATDs.</p><p><strong>Main outcomes: </strong>Survey questions were grouped largely into the domains of demographics, features of olfactory issues, impact of disorder, and support network.</p><p><strong>Results: </strong>A total of 410 participants completed the questionnaire, with the majority being women. When asked how olfactory dysfunction made participants feel, common responses included: 'sad', 'devastated', 'angry', 'anxious', 'depressed', 'isolated' and 'grief'. Family was reported as the greatest source of support when diagnosed with SATDs (partner/spouse, 36.4%; other family member, 15.1%) followed closely by SmellTaste (34%). Only 2.5% reported General Practitioners as their greatest source of support, with many participants reporting that primary care providers could not provide adequate help, leaving them to seek advice elsewhere (support groups, family, friends and self-investigation). Further support, covering medical, psychological and social interventions, was considered important.</p><p><strong>Conclusion: </strong>Given the complexity of issues experienced and the lack of formal support available for people with SATDs, there is a clear need for an intervention addressing unmet support needs.</p>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Muhammad Hammad Deewani, Muhammad Wasif Siddiqui, Hassan Danish, Muhammad Ozair Awan, Muhammad Sohail Awan, Ainulakbar Mughal, Abdul Basit Vardag, Hamdan Pasha, Haissan Iftikhar
Background: Middle ear surgery is a common procedure addressing various pathologies. Postoperative head bandaging has traditionally been used to provide support and prevent complications. However, its necessity remains controversial, with limited empirical evidence supporting its routine use.
Objective: This randomised controlled trial (RCT) evaluated the necessity of head bandaging in middle ear surgery by comparing postoperative complications between a mastoid head bandage and a simple gauze dressing.
Methods: Eighty patients scheduled for middle ear surgery were randomly assigned to two groups: the Pressure Bandage group, where a crepe bandage was wrapped around the head, and the No Pressure Bandage group, where a gauze dressing was secured with Mefix tape. All surgeries were performed by a single otolaryngologist using standardised techniques, with the surgeon blinded to the dressing type. Postoperative complications, including hematoma, erythema, skin abrasion and wound infection, were recorded and compared.
Results: The mastoid bandage group had a significantly higher incidence of forehead skin abrasions (6/40 vs. 0/40, p = 0.026). No significant differences were observed in hematoma or seroma formation, as neither group developed these complications.
Conclusion: Routine mastoid head bandaging does not appear necessary, as it does not reduce postoperative complications and may increase patient discomfort due to skin abrasions. Larger studies with longer follow-ups are recommended to strengthen these findings and guide clinical practice.
背景:中耳手术是一种常见的治疗多种病理的手术。术后头部包扎传统上用于提供支持和预防并发症。然而,它的必要性仍然存在争议,有限的经验证据支持其常规使用。目的:本随机对照试验(RCT)通过比较乳突头包扎与简单纱布包扎的术后并发症,评价中耳手术中头部包扎的必要性。方法:80例中耳手术患者随机分为两组:加压绷带组,在头部包裹皱褶绷带;无加压绷带组,用Mefix胶带固定纱布敷料。所有手术均由一名耳鼻喉科医生使用标准化技术进行,外科医生对敷料类型不知情。记录并比较术后血肿、红斑、皮肤擦伤、伤口感染等并发症。结果:乳突绷带组前额皮肤擦伤发生率明显高于对照组(6/40 vs. 0/40, p = 0.026)。两组在血肿或血肿形成方面没有显著差异,因为两组都没有出现这些并发症。结论:常规的乳突头包扎是不必要的,因为它不能减少术后并发症,并可能增加患者因皮肤擦伤而产生的不适。建议进行更大规模的研究和更长时间的随访,以加强这些发现并指导临床实践。
{"title":"Is Mastoid Head Bandage Really Required in Patients Undergoing Middle Ear Surgery? A Randomised Control Trial.","authors":"Muhammad Hammad Deewani, Muhammad Wasif Siddiqui, Hassan Danish, Muhammad Ozair Awan, Muhammad Sohail Awan, Ainulakbar Mughal, Abdul Basit Vardag, Hamdan Pasha, Haissan Iftikhar","doi":"10.1111/coa.70092","DOIUrl":"https://doi.org/10.1111/coa.70092","url":null,"abstract":"<p><strong>Background: </strong>Middle ear surgery is a common procedure addressing various pathologies. Postoperative head bandaging has traditionally been used to provide support and prevent complications. However, its necessity remains controversial, with limited empirical evidence supporting its routine use.</p><p><strong>Objective: </strong>This randomised controlled trial (RCT) evaluated the necessity of head bandaging in middle ear surgery by comparing postoperative complications between a mastoid head bandage and a simple gauze dressing.</p><p><strong>Methods: </strong>Eighty patients scheduled for middle ear surgery were randomly assigned to two groups: the Pressure Bandage group, where a crepe bandage was wrapped around the head, and the No Pressure Bandage group, where a gauze dressing was secured with Mefix tape. All surgeries were performed by a single otolaryngologist using standardised techniques, with the surgeon blinded to the dressing type. Postoperative complications, including hematoma, erythema, skin abrasion and wound infection, were recorded and compared.</p><p><strong>Results: </strong>The mastoid bandage group had a significantly higher incidence of forehead skin abrasions (6/40 vs. 0/40, p = 0.026). No significant differences were observed in hematoma or seroma formation, as neither group developed these complications.</p><p><strong>Conclusion: </strong>Routine mastoid head bandaging does not appear necessary, as it does not reduce postoperative complications and may increase patient discomfort due to skin abrasions. Larger studies with longer follow-ups are recommended to strengthen these findings and guide clinical practice.</p>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Smadar Cohen Atsmoni, Christopher J Webb, Janice Harper, Christine Burton, Andrew Kinshuck
{"title":"Non-Traumatic Subglottic Stenosis in Adults: Changing the Course of Disease.","authors":"Smadar Cohen Atsmoni, Christopher J Webb, Janice Harper, Christine Burton, Andrew Kinshuck","doi":"10.1111/coa.70089","DOIUrl":"https://doi.org/10.1111/coa.70089","url":null,"abstract":"","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146009165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}